Author

David Gygi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Anthony P. SchulleriD· 1 shared Canessa J. Swanson-Swett· 1 shared Grant W. Wienker· 1 shared Hailey K. Adams· 1 shared Justin Seiwert Sim· 1 shared Lawrence G. HamanniD· 1 shared Lillian Kenner· 1 shared Lucas FergusoniD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anthony P. SchullerORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Context-dependent translation inhibition as a novel oncology therapeutic modality

Paige D. Diamond, Paul Victor Sauer, Mikael Holm, Canessa J. Swanson-Swett, Lucas Ferguson, Natalie M. Bratset, Grant W. Wienker, Justin Seiwert Sim, Hailey K. Adams, Lillian Kenner, Margot Meyers, David Gygi, Zef A. Könst, Sogole Sami Bahmanyar, Lawrence G. Hamann, Anthony P. Schuller

This paper develops interdictors that selectively inhibit translation elongation in the human ribosome, showing their efficacy in tumor growth inhibition in a breast cancer model.

bioRxiv · Jan 9, 2025 · PreprintCancer Biology